Followers | 42 |
Posts | 1040 |
Boards Moderated | 0 |
Alias Born | 04/02/2017 |
Wednesday, August 23, 2017 9:57:56 AM
ImmunoCellular Therapeutics, Ltd. (NYSE:IMUC) has accumulated 75.71% over the course of one week. It seems that ImmunoCellular Therapeutics, Ltd. (NYSE:IMUC) might see weakness given an ABR of 4 or Sell rating. Analysts, on average, seem bullish as they suggest IMUC is worth $4.63 more, giving a target price of $5 a share.
Source:
https://allstocknews.com/2017/08/23/critical-levels-to-breach-walter-investment-management-corp-wac-immunocellular-therapeutics-ltd-imuc/
Recent IMUC News
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 08/02/2023 07:11:57 PM
FEATURED Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • Apr 22, 2024 8:49 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM